Funding

Lario Therapeutics

United Kingdom · Biotech

Develops precision medicines for epileptic and neurological disorders

Visit lariotx.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Grant$2.4MThe Michael J. Fox Foundation for Parkinson's Research — Role not disclosedWellcome — Role not disclosed

Investors

The Michael J. Fox Foundation for Parkinson's ResearchGrantWellcomeGrant

Coverage

Feb 19, 2026Lario Therapeutics · Grant

Similar companies

Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
iCUREXKagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.¥140M · Series A first close: equity and debt
Sourceslariotx.com ↗